angiotensin ii has been researched along with Intestinal Perforation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chancer, Z; Chow, JH; Galvagno, SM; Henderson, R; Mazzeffi, MA; McCurdy, MT; Tanaka, KA | 1 |
| Tyml, K; Wilson, JX; Wu, F | 1 |
2 other study(ies) available for angiotensin ii and Intestinal Perforation
| Article | Year |
|---|---|
When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.
Topics: Aged; Angiotensin II; Escherichia coli; Escherichia coli Infections; Humans; Intestinal Perforation; Male; Shock, Septic; Streptococcal Infections; Streptococcus anginosus; Treatment Outcome; Vasoplegia | 2018 |
Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression.
Topics: Angiotensin II; Animals; Arterioles; Ascorbic Acid; Blood Pressure; Cecum; Drug Administration Schedule; Enzyme Induction; Intestinal Perforation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; RNA, Messenger; Sepsis; Vasoconstriction | 2004 |